GlassScriptPhysician profile
Gordon Roedel
NPI 1851812937
$21,349.49
in general payments reported to CMS, 2019-2025
7 companies · $6,942 in 2025
The $6,942 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $350 · 2021: $553 · 2022: $6,846 · 2023: $5,848 · 2024: $697 · 2025: $6,942.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,446 · Consulting Fee: $4,513 · Travel and Lodging: $1,886 · Food and Beverage: $1,642.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,445.82 |
| Consulting Fee | $4,512.98 |
| Travel and Lodging | $1,886.31 |
| Food and Beverage | $1,642.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $10,222.32 | 2022-2023 | |
| Medical Device Business Services, INC. | $6,307.31 | 2019-2025 | Velys, Actis |
| Stryker Corporation | $3,723.44 | 2019-2025 | Mako, Insignia, Triathlon |
| Zimmer Biomet Holdings, INC. | $716.06 | 2023-2025 | Persona, Avenir, Rosa |
| Depuy Synthes Sales INC. | $306.18 | 2021-2024 | Attune |
| Medacta USA, INC. | $54.75 | 2021 | |
| Solventum Corporation | $19.43 | 2025 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gordon Roedel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.